The Measures of the General Administration of Customs of the People＇s Republic of China for Implementing the Regulations of the People＇s Repubfic of China on Customs Protection of Intellectual Property Rights discus...The Measures of the General Administration of Customs of the People＇s Republic of China for Implementing the Regulations of the People＇s Repubfic of China on Customs Protection of Intellectual Property Rights discussed and passed at the executive meeting of the General Administration of Customs （GAC） on Feb. 17, 2009 is hereby promulgated, which take effects on July 1, 2009. The Measures of the General Administration of Customs of the People＇s Republic of China for Implementing the Regulations of the People＇s Republic of China on Customs Protection of Intellectual Property Rights promulgated by No. 114 Decree of the GAC on May 25, 2004 shall be repealed simultaneously.展开更多
The Measures adopted at the Executive Meeting of the General Administration of Customs on 10 March 2008,promulgated in the form of Decree No.172 of the General Administration of Customs of the People's Republic of...The Measures adopted at the Executive Meeting of the General Administration of Customs on 10 March 2008,promulgated in the form of Decree No.172 of the General Administration of Customs of the People's Republic of China on 28 March 2008,and effective as of 1 January 2009.展开更多
Objective To investigate neutralizing antibody levels in symptomatic and asymptomatic patients with coronavirus disease 2019(COVID-19)at 6 and 10 months after disease onset.Methods Blood samples were collected at thre...Objective To investigate neutralizing antibody levels in symptomatic and asymptomatic patients with coronavirus disease 2019(COVID-19)at 6 and 10 months after disease onset.Methods Blood samples were collected at three different time points from 27 asymptomatic individuals and 69 symptomatic patients infected with severe acute respiratory syndrome coronavirus 2(SARS-Co V-2).Virus-neutralizing antibody titers against SARS-CoV-2 in both groups were measured and statistically analyzed.Results The symptomatic and asymptomatic groups had higher neutralizing antibodies at 3 months and 1–2 months post polymerase chain reaction confirmation,respectively.However,neutralizing antibodies in both groups dropped significantly to lower levels at 6 months post-PCR confirmation.Conclusion Continued monitoring of symptomatic and asymptomatic individuals with COVID-19 is key to controlling the infection.展开更多
The Western society pays close attention to China’s development,draws supposed commonalities between China and the emerging powers that have competed for international power in history,and uses the"Thucydides Tr...The Western society pays close attention to China’s development,draws supposed commonalities between China and the emerging powers that have competed for international power in history,and uses the"Thucydides Trap"to continuously amplify the"threat"posed by the growth of China’s national strength.This point of view is based on the historical practice of Western countries that take competition as the supreme value and stems from the Western logic that"a strong country will seek hegemony".However,the core fallacy of applying such stereotypes to China’s development lies in the lack of a genuine understanding of China’s cultural traditions and historical practices.The thought of peaceful development is the inherent gene of the Chinese culture.China’s gene for peace refers to the ideological,cultural and historical tradition that has been passed down from generation to generation by the Chinese nation to deal with interpersonal,social and international relations based on the principles of"harmony and peace the most precious","harmony in diversity",and"peace,concord and harmony",including the corresponding beliefs.展开更多
Dear Editor,The newly emerged severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)Omicron subvariants(XBB.1,EG.5 and JN.1)and sublineages have been circulating globally with superior growth advantages over othe...Dear Editor,The newly emerged severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)Omicron subvariants(XBB.1,EG.5 and JN.1)and sublineages have been circulating globally with superior growth advantages over other Omicron variants(Tamura et al.,2023).However,second-generation vaccines,including the BA.2 or BA.5 bivalent vaccine boosters,did not produce robust neutralization against the newly emerged XBB.1 or EG.5(Zou et al.,2023).Compared with variants BA.2 and BA.5,XBB.1 carries more mutations in the receptor binding domain(RBD)and exhibits significant immune evasion(Wang et al.,2023b).XBB.1 and its descendent lineages have rapidly become the dominant SARS-CoV-2 strain and are causing the next global wave of COVID-19.Therefore,it is essential to develop an updated vaccine against the newly emerged SARS-CoV-2 variants.展开更多
文摘The Measures of the General Administration of Customs of the People＇s Republic of China for Implementing the Regulations of the People＇s Repubfic of China on Customs Protection of Intellectual Property Rights discussed and passed at the executive meeting of the General Administration of Customs （GAC） on Feb. 17, 2009 is hereby promulgated, which take effects on July 1, 2009. The Measures of the General Administration of Customs of the People＇s Republic of China for Implementing the Regulations of the People＇s Republic of China on Customs Protection of Intellectual Property Rights promulgated by No. 114 Decree of the GAC on May 25, 2004 shall be repealed simultaneously.
文摘The Measures adopted at the Executive Meeting of the General Administration of Customs on 10 March 2008,promulgated in the form of Decree No.172 of the General Administration of Customs of the People's Republic of China on 28 March 2008,and effective as of 1 January 2009.
基金supported by the National Natural Science Foundation of China[82041027]National Key R&D Program of China[2021ZD0114100,2021ZD0114103]+2 种基金The Capital Health Development and Research of Special[2022-1G-3014]Beijing Science and Technology Planning Project of Beijing Science and Technology Commission[Z211100002521015,Z211100002521019]Cooperation project[2022-jk-cd-009]。
文摘Objective To investigate neutralizing antibody levels in symptomatic and asymptomatic patients with coronavirus disease 2019(COVID-19)at 6 and 10 months after disease onset.Methods Blood samples were collected at three different time points from 27 asymptomatic individuals and 69 symptomatic patients infected with severe acute respiratory syndrome coronavirus 2(SARS-Co V-2).Virus-neutralizing antibody titers against SARS-CoV-2 in both groups were measured and statistically analyzed.Results The symptomatic and asymptomatic groups had higher neutralizing antibodies at 3 months and 1–2 months post polymerase chain reaction confirmation,respectively.However,neutralizing antibodies in both groups dropped significantly to lower levels at 6 months post-PCR confirmation.Conclusion Continued monitoring of symptomatic and asymptomatic individuals with COVID-19 is key to controlling the infection.
文摘The Western society pays close attention to China’s development,draws supposed commonalities between China and the emerging powers that have competed for international power in history,and uses the"Thucydides Trap"to continuously amplify the"threat"posed by the growth of China’s national strength.This point of view is based on the historical practice of Western countries that take competition as the supreme value and stems from the Western logic that"a strong country will seek hegemony".However,the core fallacy of applying such stereotypes to China’s development lies in the lack of a genuine understanding of China’s cultural traditions and historical practices.The thought of peaceful development is the inherent gene of the Chinese culture.China’s gene for peace refers to the ideological,cultural and historical tradition that has been passed down from generation to generation by the Chinese nation to deal with interpersonal,social and international relations based on the principles of"harmony and peace the most precious","harmony in diversity",and"peace,concord and harmony",including the corresponding beliefs.
基金supported by a grant from the National Key R&D Program of China(2023YFC3041600 YW,the National Natural Science Foundation of China(82025001 JZ,92369113 YW,82172240 YW)Guangdong Basic and Applied Research Projects(2023B1515020040 YW,2021B1515130005 JZ,2021B1212030016 JD,2021A1111100009 JD)+7 种基金Science and Technology Planning Project of Guangzhou City(2023A04J1279 LZ)ZhongNanShan Medical Foundation of Guangdong Province(ZNSA-2020013 JZ)the Science and Technology Project of General Administration of Customs,P.R.China(2023HK065 LZ)State Key Laboratory of Respiratory Disease(SKLRD-Z-202214,SKLRD-OP-202309 YW,SKLRD-Z-202411 LZ)the Self-supporting Program of Guangzhou Laboratory(GZNL2023A01006,SRPG22-001)Guangzhou Medical University(YP2022005 YW)Korea Institute of Planning and Evaluation for Technology in Food,Agriculture and Forestry(IPET)through Animal Disease Management Technology Advancement Support Program,funded by the Ministry of Agriculture,Food and Rural Affairs(MAFRA)(122012-2,122060-2 JZ)the National Clinical Research Center for Respiratory Disease(BRD-NCRCRD,Guangzhou,Southern China).Patronus Biotech is a company researching virus-like particle display technology and vaccines.Yu Zhou and Jing Jin are named inventors on a patent invention relating to the described novel SARS-CoV-2 virus-like particle vaccine.All BALB/c mouse experiments complied with relevant ethical regulations for animal research and were approved by the LUYE PHARMA Animal Experimentation Ethics Committee.The K18-hACE2 mouse experiment was reviewed and approved by the Institutional Animal Care and Use Committees of Guangzhou Medical University(2023-0451).All authors declare that they have no conflict of interests.
文摘Dear Editor,The newly emerged severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)Omicron subvariants(XBB.1,EG.5 and JN.1)and sublineages have been circulating globally with superior growth advantages over other Omicron variants(Tamura et al.,2023).However,second-generation vaccines,including the BA.2 or BA.5 bivalent vaccine boosters,did not produce robust neutralization against the newly emerged XBB.1 or EG.5(Zou et al.,2023).Compared with variants BA.2 and BA.5,XBB.1 carries more mutations in the receptor binding domain(RBD)and exhibits significant immune evasion(Wang et al.,2023b).XBB.1 and its descendent lineages have rapidly become the dominant SARS-CoV-2 strain and are causing the next global wave of COVID-19.Therefore,it is essential to develop an updated vaccine against the newly emerged SARS-CoV-2 variants.
